Annual Total Debt
$58.00 K
-$116.00 K-66.67%
31 December 2023
Summary:
GT Biopharma annual total debt is currently $58.00 thousand, with the most recent change of -$116.00 thousand (-66.67%) on 31 December 2023. During the last 3 years, it has fallen by -$26.28 million (-99.78%). GTBP annual total debt is now -99.78% below its all-time high of $26.33 million, reached on 31 December 2020.GTBP Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$0.00
$0.000.00%
30 September 2024
Summary:
GT Biopharma quarterly total debt is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$92.00 thousand (-100.00%). GTBP quarterly total debt is now -100.00% below its all-time high of $26.33 million, reached on 31 December 2020.GTBP Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -66.7% | -100.0% |
| 3 y3 years | -99.8% | -100.0% |
| 5 y5 years | -99.5% | -100.0% |
GTBP Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -99.8% | +87.1% | -100.0% | |
| 5 y | 5 years | -99.8% | +87.1% | -100.0% | |
| alltime | all time | -99.8% | -100.0% |
GT Biopharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $0.00(0.0%) |
| June 2024 | - | $0.00(-100.0%) |
| Mar 2024 | - | $30.00 K(-48.3%) |
| Dec 2023 | $58.00 K(-66.7%) | $58.00 K(-37.0%) |
| Sept 2023 | - | $92.00 K(-23.3%) |
| June 2023 | - | $120.00 K(-18.4%) |
| Mar 2023 | - | $147.00 K(-15.5%) |
| Dec 2022 | $174.00 K(+461.3%) | $174.00 K(-12.1%) |
| Sept 2022 | - | $198.00 K(-11.2%) |
| June 2022 | - | $223.00 K(-9.7%) |
| Mar 2022 | - | $247.00 K(+696.8%) |
| Dec 2021 | $31.00 K(-99.9%) | $31.00 K(0.0%) |
| Sept 2021 | - | $31.00 K(0.0%) |
| June 2021 | - | $31.00 K(0.0%) |
| Mar 2021 | - | $31.00 K(-99.9%) |
| Dec 2020 | $26.33 M(+97.1%) | $26.33 M(+13.9%) |
| Sept 2020 | - | $23.11 M(+5.2%) |
| June 2020 | - | $21.96 M(+64.0%) |
| Mar 2020 | - | $13.39 M(+0.3%) |
| Dec 2019 | $13.36 M(+23.6%) | $13.36 M(+0.4%) |
| Sept 2019 | - | $13.31 M(+7.8%) |
| June 2019 | - | $12.35 M(+7.5%) |
| Mar 2019 | - | $11.49 M(+6.3%) |
| Dec 2018 | $10.80 M(>+9900.0%) | $10.80 M(+1.7%) |
| Sept 2018 | - | $10.63 M(+54.3%) |
| June 2018 | - | $6.89 M(+132.4%) |
| Mar 2018 | - | $2.96 M(+9458.1%) |
| Dec 2017 | $31.00 K(-99.8%) | $31.00 K(0.0%) |
| Sept 2017 | - | $31.00 K(-99.8%) |
| June 2017 | - | $12.42 M(+5.3%) |
| Mar 2017 | - | $11.79 M(-5.0%) |
| Dec 2016 | $12.41 M(+27.4%) | $12.41 M(+9.9%) |
| Sept 2016 | - | $11.29 M(+6.5%) |
| June 2016 | - | $10.60 M(+0.2%) |
| Mar 2016 | - | $10.58 M(+8.5%) |
| Dec 2015 | $9.75 M(+190.2%) | $9.75 M(+59.8%) |
| Sept 2015 | - | $6.10 M(+38.5%) |
| June 2015 | - | $4.40 M(+17.1%) |
| Mar 2015 | - | $3.76 M(+11.9%) |
| Dec 2014 | $3.36 M(+29.8%) | $3.36 M(+11.5%) |
| Sept 2014 | - | $3.01 M(+6.7%) |
| June 2014 | - | $2.82 M(+3.6%) |
| Mar 2014 | - | $2.73 M(+5.3%) |
| Dec 2013 | $2.59 M(+37.7%) | $2.59 M(+14.0%) |
| Sept 2013 | - | $2.27 M(+4.8%) |
| June 2013 | - | $2.17 M(+12.6%) |
| Mar 2013 | - | $1.93 M(+2.4%) |
| Dec 2012 | $1.88 M(-8.8%) | $1.88 M(-29.9%) |
| Sept 2012 | - | $2.68 M(+21.5%) |
| June 2012 | - | $2.21 M(+0.2%) |
| Mar 2012 | - | $2.20 M(+6.7%) |
| Dec 2011 | $2.06 M(-4.8%) | $2.06 M(+940.9%) |
| Sept 2011 | - | $198.00 K(-90.5%) |
| June 2011 | - | $2.09 M(+2.7%) |
| Mar 2011 | - | $2.04 M(-5.8%) |
| Dec 2010 | $2.16 M(-8.8%) | $2.16 M(-0.4%) |
| Sept 2010 | - | $2.17 M(-7.0%) |
| June 2010 | - | $2.34 M(-10.2%) |
| Mar 2010 | - | $2.60 M(+9.6%) |
| Dec 2009 | $2.37 M(+10.5%) | $2.37 M(+3.5%) |
| Sept 2009 | - | $2.29 M(+4.5%) |
| June 2009 | - | $2.19 M(+1.7%) |
| Mar 2009 | - | $2.16 M(+0.5%) |
| Dec 2008 | $2.15 M(>+9900.0%) | $2.15 M(+0.2%) |
| Sept 2008 | - | $2.14 M(+99.5%) |
| June 2008 | - | $1.07 M(+11.2%) |
| Mar 2008 | - | $966.00 K(>+9900.0%) |
| Dec 2007 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2007 | - | $628.00 K(+37.1%) |
| June 2007 | - | $458.00 K(+57.9%) |
| Mar 2007 | - | $290.00 K(-90.9%) |
| Dec 2006 | $3.18 M(+4.1%) | $3.18 M(-10.2%) |
| Sept 2006 | - | $3.54 M(-3.1%) |
| June 2006 | - | $3.66 M(0.0%) |
| Mar 2006 | - | $3.66 M(+19.6%) |
| Dec 2005 | $3.06 M(+125.0%) | $3.06 M(>+9900.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(-100.0%) |
| Mar 2005 | - | $160.00 K(-88.2%) |
| Dec 2004 | $1.36 M | $1.36 M(-22.9%) |
| Sept 2004 | - | $1.76 M(+8.8%) |
| June 2004 | - | $1.62 M(+481.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2004 | - | $279.00 K(+74.4%) |
| Dec 2003 | $160.00 K(0.0%) | $160.00 K(0.0%) |
| Sept 2003 | - | $160.00 K(0.0%) |
| June 2003 | - | $160.00 K(0.0%) |
| Mar 2003 | - | $160.00 K(0.0%) |
| Dec 2002 | $160.00 K(-37.0%) | $160.00 K(-3.6%) |
| Sept 2002 | - | $166.00 K(-8.3%) |
| June 2002 | - | $181.00 K(-12.6%) |
| Mar 2002 | - | $207.00 K(-18.5%) |
| Dec 2001 | $254.00 K(-37.9%) | $254.00 K(-10.6%) |
| Sept 2001 | - | $284.00 K(-37.0%) |
| June 2001 | - | $451.00 K(+12.2%) |
| Mar 2001 | - | $402.00 K(-1.7%) |
| Dec 2000 | $409.00 K(-57.8%) | $409.00 K(-41.7%) |
| Sept 2000 | - | $701.00 K(-1.1%) |
| June 2000 | - | $709.00 K(-2.9%) |
| Mar 2000 | - | $730.00 K(-24.7%) |
| Dec 1999 | $969.00 K(-59.8%) | $969.00 K(+7.7%) |
| Sept 1999 | - | $900.00 K(-10.0%) |
| June 1999 | - | $1.00 M(0.0%) |
| Mar 1999 | - | $1.00 M(-58.6%) |
| Dec 1998 | $2.41 M(-22.2%) | $2.41 M(+0.5%) |
| Sept 1998 | - | $2.40 M(-11.1%) |
| June 1998 | - | $2.70 M(-15.6%) |
| Mar 1998 | - | $3.20 M(+3.2%) |
| Dec 1997 | $3.10 M(+138.5%) | $3.10 M(+158.3%) |
| Sept 1997 | - | $1.20 M(0.0%) |
| June 1997 | - | $1.20 M(-20.0%) |
| Mar 1997 | - | $1.50 M(+15.4%) |
| Dec 1996 | $1.30 M(-59.4%) | $1.30 M(+225.0%) |
| Sept 1996 | - | $400.00 K(-20.0%) |
| June 1996 | - | $500.00 K(-84.4%) |
| Mar 1996 | - | $3.20 M(0.0%) |
| Dec 1995 | $3.20 M(+190.9%) | $3.20 M(+52.4%) |
| Sept 1995 | - | $2.10 M(-8.7%) |
| June 1995 | - | $2.30 M(+35.3%) |
| Mar 1995 | - | $1.70 M(+54.5%) |
| Dec 1994 | $1.10 M(>+9900.0%) | $1.10 M(+10.0%) |
| Sept 1994 | - | $1.00 M(>+9900.0%) |
| June 1994 | - | $0.00(0.0%) |
| Mar 1994 | - | $0.00(0.0%) |
| Dec 1993 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1993 | - | $0.00(0.0%) |
| June 1993 | - | $0.00(0.0%) |
| Mar 1993 | - | $0.00(0.0%) |
| Dec 1992 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1992 | - | $0.00(0.0%) |
| June 1992 | - | $0.00(0.0%) |
| Mar 1992 | - | $0.00(0.0%) |
| Dec 1991 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1991 | - | $0.00(0.0%) |
| June 1991 | - | $0.00(0.0%) |
| Mar 1991 | - | $0.00(0.0%) |
| Dec 1990 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1990 | - | $0.00(0.0%) |
| June 1990 | - | $0.00(0.0%) |
| Mar 1990 | - | $0.00(0.0%) |
| Dec 1989 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1989 | - | $0.00(0.0%) |
| June 1989 | - | $0.00(0.0%) |
| Mar 1989 | - | $0.00(0.0%) |
| Dec 1988 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1988 | - | $0.00(0.0%) |
| June 1988 | - | $0.00(0.0%) |
| Mar 1988 | - | $0.00(0.0%) |
| Dec 1987 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1987 | - | $0.00(0.0%) |
| June 1987 | - | $0.00(0.0%) |
| Mar 1987 | - | $0.00(0.0%) |
| Dec 1986 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1986 | - | $0.00(0.0%) |
| June 1986 | - | $0.00(0.0%) |
| Mar 1986 | - | $0.00(0.0%) |
| Dec 1985 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1985 | - | $0.00(0.0%) |
| June 1985 | - | $0.00(0.0%) |
| Mar 1985 | - | $0.00(0.0%) |
| Dec 1984 | $0.00(0.0%) | - |
| Dec 1984 | - | $0.00(0.0%) |
| Sept 1984 | - | $0.00(0.0%) |
| June 1984 | - | $0.00(0.0%) |
| Mar 1984 | - | $0.00 |
| Feb 1984 | $0.00 | - |
FAQ
- What is GT Biopharma annual total debt?
- What is the all time high annual total debt for GT Biopharma?
- What is GT Biopharma annual total debt year-on-year change?
- What is GT Biopharma quarterly total debt?
- What is the all time high quarterly total debt for GT Biopharma?
- What is GT Biopharma quarterly total debt year-on-year change?
What is GT Biopharma annual total debt?
The current annual total debt of GTBP is $58.00 K
What is the all time high annual total debt for GT Biopharma?
GT Biopharma all-time high annual total debt is $26.33 M
What is GT Biopharma annual total debt year-on-year change?
Over the past year, GTBP annual total debt has changed by -$116.00 K (-66.67%)
What is GT Biopharma quarterly total debt?
The current quarterly total debt of GTBP is $0.00
What is the all time high quarterly total debt for GT Biopharma?
GT Biopharma all-time high quarterly total debt is $26.33 M
What is GT Biopharma quarterly total debt year-on-year change?
Over the past year, GTBP quarterly total debt has changed by -$92.00 K (-100.00%)